Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02779062 · ClinicalTrials.gov registry record
Apparent Life Threatening Events in Infants
A clinical trial of ALTE, sponsored by NYU Langone Health.
- Completed
- Registry status
- 22
- Enrollment target
- 1
- Study location
NCT02779062: Completed study of ALTE, sponsored by NYU Langone Health.
NCT02779062 is a study of ALTE that has completed, run by NYU Langone Health. The registered enrollment target is 22 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02779062, a study of ALTE, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- 22 participants
- Enrollment target
- 1
- Study location
Study Summary
Infants sometimes experience sudden symptoms such as breathing irregularities or limpness that frighten parents and prompt them to seek emergency medical care. While few of these episodes are truly life-threatening and require hospital admission, some parents may have been so frightened that they will resist returning home from the emergency department with their baby even if the objective risk is extremely small. Study subjects (parents of infants with an apparent life threatening event) will be contacted and interviewed. Investigators want to learn whether or not study subjects would accept returning home after a brief period of observation in the emergency department if the physician determines that it is safe to do so.
Primary Outcome
Subject response (yes or no) to the following question: Would you have felt comfortable returning home from the emergency department with your baby (rather than admitting baby to the hospital overnight) if the medical evaluation in the emergency department had determined that it would be safe to do so? This question will be asked within the context of a series of questions addressing the subject's experience following the apparent life-threatening event of their infant.
Conditions Studied
Interventions
- OTHER Interview
Study Locations (1)
New York
- Winthrop University Hospital - Mineola
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2015-03 |
| Est. Completion | 2016-12 |
What the finished NCT02779062 record still lists
NCT02779062 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 22 participants, a relatively small participant target.
The record links to 1 condition, with ALTE appearing as the primary indexed condition, and to 1 intervention - of which Interview is the first listed.
NCT02779062 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT02779062 about?
NCT02779062 is a clinical study titled "Apparent Life Threatening Events in Infants". Infants sometimes experience sudden symptoms such as breathing irregularities or limpness that frighten parents and prompt them to seek emergency medical care. While few of these episodes are truly life-threatening and require hospital admission, some parents may have been so frightened that they wi...
What is the current status of trial NCT02779062?
This trial is currently completed. The enrollment target is 22 participants. The study started on 2015-03. Estimated completion is 2016-12.
What conditions does trial NCT02779062 study?
This clinical trial studies the following conditions: ALTE.
What interventions are being tested in trial NCT02779062?
The interventions under investigation include: Interview (OTHER).
Who is sponsoring clinical trial NCT02779062?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02779062 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02508038 · 22 participants · Phase 1
Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors
- NCT03099356 · 22 participants · Phase 2
Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer
- NCT03676647 · 22 participants
Diagnostic DNA Methylation Signature in Diagnosing Thyroid Cancer After Fine-Needle Aspiration in Patients With Thyroid Nodules
- NCT04569591 · 22 participants · NA
DDAVP for Pituitary Adenoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia